Medical - Diagnostics & Research
Compare Stocks
5 / 10Stock Comparison
WAT vs A vs BRKR vs MTSI vs SHIM
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Diagnostics & Research
Medical - Devices
Semiconductors
Engineering & Construction
WAT vs A vs BRKR vs MTSI vs SHIM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Diagnostics & Research | Medical - Diagnostics & Research | Medical - Devices | Semiconductors | Engineering & Construction |
| Market Cap | $22.83B | $33.58B | $6.66B | $25.84B | $204M |
| Revenue (TTM) | $3.77B | $7.07B | $3.46B | $1.07B | $493M |
| Net Income (TTM) | $449M | $1.29B | $-12M | $177M | $-26M |
| Gross Margin | 55.0% | 38.8% | 45.3% | 55.3% | 6.8% |
| Operating Margin | 17.1% | 20.6% | 4.9% | 16.0% | -3.9% |
| Forward P/E | 24.4x | 19.9x | 20.7x | 76.9x | — |
| Total Debt | $1.41B | $3.35B | $2.04B | $538M | $16M |
| Cash & Equiv. | $588M | $1.79B | $299M | $112M | $20M |
WAT vs A vs BRKR vs MTSI vs SHIM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 23 | May 26 | Return |
|---|---|---|---|
| Waters Corporation (WAT) | 100 | 124.8 | +24.8% |
| Agilent Technologie… (A) | 100 | 92.8 | -7.2% |
| Bruker Corporation (BRKR) | 100 | 67.2 | -32.8% |
| MACOM Technology So… (MTSI) | 100 | 410.2 | +310.2% |
| Shimmick Corporatio… (SHIM) | 100 | 91.5 | -8.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WAT vs A vs BRKR vs MTSI vs SHIM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
WAT is the #2 pick in this set and the best alternative if stability is your priority.
- Beta 1.07 vs SHIM's 1.78
A carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 10 yrs, beta 1.23, yield 0.8%
- Lower volatility, beta 1.23, Low D/E 49.8%, current ratio 1.96x
- PEG 1.35 vs WAT's 4.70
- Beta 1.23, yield 0.8%, current ratio 1.96x
Among these 5 stocks, BRKR doesn't own a clear edge in any measured category.
MTSI ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 32.6%, EPS growth -170.2%, 3Y rev CAGR 12.7%
- 8.0% 10Y total return vs A's 205.7%
- 32.6% revenue growth vs BRKR's 2.1%
SHIM is the clearest fit if your priority is momentum.
- +302.1% vs WAT's +1.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.6% revenue growth vs BRKR's 2.1% | |
| Value | Better valuation composite | |
| Quality / Margins | 18.3% margin vs SHIM's -5.2% | |
| Stability / Safety | Beta 1.07 vs SHIM's 1.78 | |
| Dividends | 0.8% yield, 10-year raise streak, vs BRKR's 0.3%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +302.1% vs WAT's +1.4% | |
| Efficiency (ROA) | 10.1% ROA vs SHIM's -11.8% |
WAT vs A vs BRKR vs MTSI vs SHIM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
WAT vs A vs BRKR vs MTSI vs SHIM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
A leads in 2 of 6 categories
MTSI leads 1 • WAT leads 0 • BRKR leads 0 • SHIM leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — A and MTSI each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
A is the larger business by revenue, generating $7.1B annually — 14.3x SHIM's $493M. A is the more profitable business, keeping 18.3% of every revenue dollar as net income compared to SHIM's -5.2%. On growth, WAT holds the edge at +91.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.8B | $7.1B | $3.5B | $1.1B | $493M |
| EBITDAEarnings before interest/tax | $953M | $1.7B | $397M | $210M | -$10M |
| Net IncomeAfter-tax profit | $449M | $1.3B | -$12M | $177M | -$26M |
| Free Cash FlowCash after capex | $264M | $993M | $51M | $168M | -$71M |
| Gross MarginGross profit ÷ Revenue | +55.0% | +38.8% | +45.3% | +55.3% | +6.8% |
| Operating MarginEBIT ÷ Revenue | +17.1% | +20.6% | +4.9% | +16.0% | -3.9% |
| Net MarginNet income ÷ Revenue | +11.9% | +18.3% | -0.3% | +16.5% | -5.2% |
| FCF MarginFCF ÷ Revenue | +7.0% | +14.1% | +1.5% | +15.6% | -14.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +91.5% | +7.0% | +2.7% | +22.5% | -3.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -142.9% | -3.6% | -79.2% | +42.9% | +92.6% |
Valuation Metrics
A leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 26.0x trailing earnings, A trades at a 20% valuation discount to WAT's 32.6x P/E. Adjusting for growth (PEG ratio), A offers better value at 1.76x vs WAT's 6.29x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $22.8B | $33.6B | $6.7B | $25.8B | $204M |
| Enterprise ValueMkt cap + debt − cash | $23.7B | $35.1B | $8.4B | $26.3B | $200M |
| Trailing P/EPrice ÷ TTM EPS | 32.55x | 25.96x | -291.53x | -471.88x | -7.66x |
| Forward P/EPrice ÷ next-FY EPS est. | 24.36x | 19.87x | 20.68x | 76.91x | — |
| PEG RatioP/E ÷ EPS growth rate | 6.29x | 1.76x | — | — | — |
| EV / EBITDAEnterprise value multiple | 21.51x | 19.89x | 18.41x | 136.13x | — |
| Price / SalesMarket cap ÷ Revenue | 7.21x | 4.83x | 1.94x | 26.71x | 0.41x |
| Price / BookPrice ÷ Book value/share | 8.17x | 5.00x | 2.64x | 19.20x | — |
| Price / FCFMarket cap ÷ FCF | 42.30x | 29.15x | 153.73x | 134.01x | — |
Profitability & Efficiency
Evenly matched — A and MTSI and SHIM each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
A delivers a 18.7% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-0 for BRKR. MTSI carries lower financial leverage with a 0.41x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRKR's 0.81x. On the Piotroski fundamental quality scale (0–9), A scores 5/9 vs BRKR's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.0% | +18.7% | -0.5% | +13.2% | — |
| ROA (TTM)Return on assets | +4.6% | +10.1% | -0.2% | +8.6% | -11.8% |
| ROICReturn on invested capital | +20.3% | +13.5% | +4.4% | +6.0% | — |
| ROCEReturn on capital employed | +18.5% | +14.5% | +5.0% | +7.6% | -147.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 4 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.55x | 0.50x | 0.81x | 0.41x | — |
| Net DebtTotal debt minus cash | $820M | $1.6B | $1.7B | $426M | -$4M |
| Cash & Equiv.Liquid assets | $588M | $1.8B | $299M | $112M | $20M |
| Total DebtShort + long-term debt | $1.4B | $3.4B | $2.0B | $538M | $16M |
| Interest CoverageEBIT ÷ Interest expense | 6.72x | 19.53x | 1.14x | 391.47x | -2.82x |
Total Returns (Dividends Reinvested)
MTSI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MTSI five years ago would be worth $61,359 today (with dividends reinvested), compared to $6,447 for BRKR. Over the past 12 months, SHIM leads with a +302.1% total return vs WAT's +1.4%. The 3-year compound annual growth rate (CAGR) favors MTSI at 84.4% vs BRKR's -16.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -8.3% | -13.6% | -9.0% | +96.9% | +85.9% |
| 1-Year ReturnPast 12 months | +1.4% | +11.3% | +7.8% | +203.8% | +302.1% |
| 3-Year ReturnCumulative with dividends | +18.1% | -8.2% | -42.5% | +526.9% | -11.4% |
| 5-Year ReturnCumulative with dividends | +11.3% | -8.0% | -35.5% | +513.6% | -11.4% |
| 10-Year ReturnCumulative with dividends | +162.0% | +205.7% | +67.1% | +795.9% | -11.4% |
| CAGR (3Y)Annualised 3-year return | +5.7% | -2.8% | -16.9% | +84.4% | -4.0% |
Risk & Volatility
Evenly matched — WAT and MTSI each lead in 1 of 2 comparable metrics.
Risk & Volatility
WAT is the less volatile stock with a 1.07 beta — it tends to amplify market swings less than SHIM's 1.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MTSI currently trades 97.0% from its 52-week high vs A's 74.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.07x | 1.23x | 1.59x | 1.75x | 1.78x |
| 52-Week HighHighest price in past year | $414.15 | $160.27 | $56.22 | $355.00 | $6.76 |
| 52-Week LowLowest price in past year | $275.05 | $104.79 | $28.53 | $110.09 | $1.30 |
| % of 52W HighCurrent price vs 52-week peak | +84.6% | +74.0% | +77.8% | +97.0% | +83.8% |
| RSI (14)Momentum oscillator 0–100 | 64.9 | 52.5 | 64.8 | 71.3 | 60.2 |
| Avg Volume (50D)Average daily shares traded | 999K | 2.0M | 1.9M | 1.1M | 161K |
Analyst Outlook
A leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WAT as "Hold", A as "Buy", BRKR as "Buy", MTSI as "Buy", SHIM as "Hold". Consensus price targets imply 39.9% upside for A (target: $166) vs -26.3% for MTSI (target: $254). For income investors, A offers the higher dividend yield at 0.84% vs BRKR's 0.34%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $402.57 | $166.00 | $52.13 | $254.00 | $6.00 |
| # AnalystsCovering analysts | 34 | 38 | 32 | 23 | 2 |
| Dividend YieldAnnual dividend ÷ price | — | +0.8% | +0.3% | — | — |
| Dividend StreakConsecutive years of raises | 1 | 10 | 0 | 0 | — |
| Dividend / ShareAnnual DPS | — | $0.99 | $0.15 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +1.3% | +0.2% | +0.2% | 0.0% |
A leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). MTSI leads in 1 (Total Returns). 3 tied.
WAT vs A vs BRKR vs MTSI vs SHIM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is WAT or A or BRKR or MTSI or SHIM a better buy right now?
For growth investors, MACOM Technology Solutions Holdings, Inc.
(MTSI) is the stronger pick with 32. 6% revenue growth year-over-year, versus 2. 1% for Bruker Corporation (BRKR). Agilent Technologies, Inc. (A) offers the better valuation at 26. 0x trailing P/E (19. 9x forward), making it the more compelling value choice. Analysts rate Agilent Technologies, Inc. (A) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — WAT or A or BRKR or MTSI or SHIM?
On trailing P/E, Agilent Technologies, Inc.
(A) is the cheapest at 26. 0x versus Waters Corporation at 32. 6x. On forward P/E, Agilent Technologies, Inc. is actually cheaper at 19. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Agilent Technologies, Inc. wins at 1. 35x versus Waters Corporation's 4. 70x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — WAT or A or BRKR or MTSI or SHIM?
Over the past 5 years, MACOM Technology Solutions Holdings, Inc.
(MTSI) delivered a total return of +513. 6%, compared to -35. 5% for Bruker Corporation (BRKR). Over 10 years, the gap is even starker: MTSI returned +795. 9% versus SHIM's -11. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — WAT or A or BRKR or MTSI or SHIM?
By beta (market sensitivity over 5 years), Waters Corporation (WAT) is the lower-risk stock at 1.
07β versus Shimmick Corporation Common Stock's 1. 78β — meaning SHIM is approximately 66% more volatile than WAT relative to the S&P 500. On balance sheet safety, MACOM Technology Solutions Holdings, Inc. (MTSI) carries a lower debt/equity ratio of 41% versus 81% for Bruker Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — WAT or A or BRKR or MTSI or SHIM?
By revenue growth (latest reported year), MACOM Technology Solutions Holdings, Inc.
(MTSI) is pulling ahead at 32. 6% versus 2. 1% for Bruker Corporation (BRKR). On earnings-per-share growth, the picture is similar: Shimmick Corporation Common Stock grew EPS 82. 0% year-over-year, compared to -170. 2% for MACOM Technology Solutions Holdings, Inc.. Over a 3-year CAGR, MTSI leads at 12. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — WAT or A or BRKR or MTSI or SHIM?
Waters Corporation (WAT) is the more profitable company, earning 20.
3% net margin versus -5. 6% for MACOM Technology Solutions Holdings, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WAT leads at 28. 2% versus -3. 9% for SHIM. At the gross margin level — before operating expenses — WAT leads at 57. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is WAT or A or BRKR or MTSI or SHIM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Agilent Technologies, Inc. (A) is the more undervalued stock at a PEG of 1. 35x versus Waters Corporation's 4. 70x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Agilent Technologies, Inc. (A) trades at 19. 9x forward P/E versus 76. 9x for MACOM Technology Solutions Holdings, Inc. — 57. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for A: 39. 9% to $166. 00.
08Which pays a better dividend — WAT or A or BRKR or MTSI or SHIM?
In this comparison, A (0.
8% yield), BRKR (0. 3% yield) pay a dividend. WAT, MTSI, SHIM do not pay a meaningful dividend and should not be held primarily for income.
09Is WAT or A or BRKR or MTSI or SHIM better for a retirement portfolio?
For long-horizon retirement investors, Agilent Technologies, Inc.
(A) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 23), 0. 8% yield, +205. 7% 10Y return). Shimmick Corporation Common Stock (SHIM) carries a higher beta of 1. 78 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (A: +205. 7%, SHIM: -11. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between WAT and A and BRKR and MTSI and SHIM?
These companies operate in different sectors (WAT (Healthcare) and A (Healthcare) and BRKR (Healthcare) and MTSI (Technology) and SHIM (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: WAT is a mid-cap quality compounder stock; A is a mid-cap quality compounder stock; BRKR is a small-cap quality compounder stock; MTSI is a mid-cap high-growth stock; SHIM is a small-cap quality compounder stock. A pays a dividend while WAT, BRKR, MTSI, SHIM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.